The influence of the oncogenes NRAS and MYC on the radiation sensitivity of cells of a human melanoma cell line

Radiation Research

Volumn 146, Issue 4, 1996, Pages 374-381

  Pomp, J ^a,b   Ouwerkerk, I J M ^a   Hermans, J ^a   Wondergem, J ^a   Cornelisse, C J ^a   Leer, J W H ^a   Schrier, P I ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b REINIER DE GRAAF HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CELL SURVIVAL; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IRRADIATION; ONCOGENE MYC; POINT MUTATION; PRIORITY JOURNAL; PROTO ONCOGENE; RADIOSENSITIVITY;

EID: 0029780350     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3579299     Document Type: Article

References (43)

1. M. D. Sklar, The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation. Science 239, 645-647 (1988).
2. W. G. McKenna, M. C. Weiss, B. Endlich, C. C. Ling, V. J. Bakanauskas, M. L. Relsten and R. J. Muschel, Synergistic effect of the v-myc oncogene with H-ras on radioresistance. Cancer Res. 50, 97-102 (1990).
3. W. G. McKenna, M. C. Weiss, V. J. Bakanauskas, H. Sandier, M. L. Kelsten, J. Biaglow, S. W. Tuttle, B. Endlich, C. C. Ling and R. J. Muschel, The role of the H-ras oncogene in radiation resistance and metastasis. Int. J. Radiat. Oncol. Biol. Phys. 18, 849-859 (1990).
4. 2 delay in radiation-resistant cells obtained by transformation of primary rat embryo cells with the oncogenes H-ras and v-myc. Radiat. Res. 125, 283-287 (1991).
5. D. Samid, A. C. Miller, D. Rimoldi, J. Gafner and E. P. Clark, Increased radiation resistance in transformed and nontransformed cells with elevated ras proto-oncogene expression. Radiat. Res. 126, 244-250 (1991).
6. 2. Int. J. Radiat. Biol. 63, 623-629 (1993).
7. Y. Wang and G. Iliakis, Prolonged inhibition by X-rays of DNA synthesis in cells obtained by transformation of primary rat embryo fibroblasts with oncogenes H-ras and v-myc. Cancer Res. 52, 508-514 (1992).
8. A. F. Hermens and P. A. Bentvelzen, Influence of the H-ras oncogene on radiation responses of a rat rhabdomyosarcoma cell line. Cancer Res. 52, 3073-3082 (1992).
9. A. Ong, W. X. Li and C. C. Ling, Low-dose-rate irradiation of rat embryo cells containing the H-ras oncogene. Radiat. Res. 134, 251-255 (1993).
10. E. H. Chang, K. F. Pirollo, Z. Q. Zou, H-Y. Cheung, E. L. Lawler, R. Garner, E. White, W. B. Bernstein, J. W. Fraumeni, Jr. and W. A. Blattner, Oncogenes in radioresistant, noncancerous skin fibroblasts from a cancer-prone family. Science 237, 1036-1039 (1987).
11. T. J. FitzGerald, M. A. Santucci, I. Das, K. Kase, J. H. Pierce and J. S. Greenberger, The V-ABL, C-FMS, or V-MYC oncogene induces gamma-radiation resistance of hematopoietic progenitor cell line 32d CL 3 at clinical low dose rate. Int. J. Radiat. Oncol. Biol. Phys. 21, 1203-1210 (1991).
12. K. F. Pirollo, Y. A. Tong, Z. Villegas, Y. Chen and E. H. Chang, Oncogene-transformed NIH-3T3 cells display radiation resistance levels indicative of a signal transduction pathway leading to the radiation-resistant phenotype. Radiat. Res. 135, 234-243 (1993).
13. U. Kasid, A. Pfeifer, R. R. Weichselbaum, A. Dritschilo and G. E. Mark, The raf oncogene is associated with a radiation-resistant human laryngeal cancer. Science 237, 1039-1041 (1987).
14. T. J. FitzGerald, S. Henault, M. Sakakeeny, M. A. Santucci, J. H. Pierce, P. Anklesaria, K. Kase, I. Das and J. S. Greenberger, Expression of transfected recombinant oncogenes increases radiation resistance of clonal hematopoietic and fibroblast cell lines selectively at clinical low dose rate. Radiat. Res. 122, 44-52 (1990).
15. E. A. Bruyneel, G. A. Storme, D. C. C. Schallier, D. L. Vandenberge, P. Hilgard and M. M. Marcel, Evidence for abrogation of oncogene-induced radioresistance of mammary cancer cells by hexadecylphosphocholine in vitro. Eur. J. Cancer 29A, 1958-1963 (1993).
16. C. Alapetite, C. Baroche, Y. Remvikos, G. Goubin and E. Moustacchi, Studies on the influence of the presence of an activated ras oncogene on the in vitro radiosensitivity of human mammary epithelial cells. Int. J. Radiat. Biol. 59, 385-396 (1991).
17. L. N. Su and J. B. Little, Transformation and radiosensitivity of human diploid skin fibroblasts transfected with activated ras oncogene and SV40 T-antigen. Int. J. Radiat. Biol. 62, 201-210 (1992).
18. M. S. Mendonca, P. Boukamp, E. J. Stanbridge and J. L. Redpath, The radiosensitivity of human keratinocytes: influence of activated c-H-ras oncogene expression and tumorigenicity. Int. J. Radiat. Biol. 59, 1195-1206 (1991).
19. M. L. Grant, R. K. Bruton, P. J. Byrd, P. H. Gallimore, J. C. Steel, A. M. R. Taylor and R. J. A. Grand, Sensitivity to ionising radiation of transformed human cells containing mutant ras genes. Oncogene 5, 1159-1164 (1990).
20. M. A. Santucci, P. Anklesaria, S. M. Anderson, J. J. Das, T. J. FitzGerald, H. Valinsky, K. P. Kase, M. A. Sakakeeny and J. S. Greenberger, The v-src oncogene may not be responsible for the increased radioresistance of hematopoietic progenitor cells expressing v-src. Radiat. Res. 129, 297-303 (1992).
21. L. J. Van 't Veer, B. M. T. Burgering, R. Versteeg, A. J. M. Boot, D. J. Ruiter, S. Osanto, P. I. Schrier and J. L. Bos, N-ras mutations in human cutaneous melanoma on sun-exposed body sites. Mol. Cell. Biol. 9, 3114-3116 (1989).
22. P. I. Schrier, R. Versteeg, L. T. C. Peltenburg, A. C. Plomp, L. J. Van 't Veer and K. M. Krüse-Welters, Sensitivity of melanoma cell lines to natural killer cells: a role for oncogene-modulated HLA expression? Semin. Cancer Biol. 2, 73-83 (1991).
23. R. Versteeg, I. A. Noordermeer, K. M. Krüse-Wolters, D. J. Ruiter and P. I. Schrier, C-myc downregulates class I HLA expression in human melanomas. EMBO J. 7, 1023-1029 (1988).
24. C. Aubert, F. Rouge and J. R. Galindo, Tumorigenicity of human malignant melanocytes in nude mice in relation to their differentiation in vitro. J. Natl Cancer Inst. 64, 1029-1040 (1980).
25. Y. F. Lau and Y. W. Kan, Versatile cosmid vectors for the isolation, expression, and rescue of gene sequences: studies with the human alpha-globin gene cluster. Proc. Natl. Acad. Sci. USA 80, 5225-5229 (1983).
26. F. L. Graham and A. J. van der Eb, Transformation of rat cells by DNA of human adenovirus 5. Virology 54, 536-539 (1973).
27. A. Van Elsas, E. Van Deursen, R. Wielders, C. A. M. Van den Berg-Bakker and P. I. Schrier, Ras oncogene activation does not induce sensitivity to natural killer cell-mediated lysis in human melanoma. J. Invest. Dermatol. 103, 117S-121S (1994).
28. L. T. C. Peltenburg, W. T. Steegenga, K. M. Krüse and P. I. Schrier, C-myc-induced natural killer cell sensitivity of human melanoma cells is reversed by HLA-B27 transfection. Eur. J. Immunol. 22, 2737-2740 (1992).
29. C. Auffray and F. Rougeon, Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur. J. Biochem. 107, 303-314 (1980).
30. A. P. Feinberg and B. Vogelstein, A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132, 6-13 (1983).
31. R. Versteeg, L. T. C. Peltenhurg, A. C. Plomp and P. I. Schrier, High expression of the c-myc oncogene renders melanoma cells prone to lysis by natural killer cells. J. Immunol. 143, 4331-4337 (1989).
32. R. Bernards, N-myc disrupts protein kinase C-mediated signal transduction in neuroblastoma. EMBO J. 10, 1119-1125 (1991).
33. W. N. Burnette, Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem. 112, 195-203 (1981).
34. G. I. Evan, G. K. Lewis, G. Ramsay and J. M. Bishop. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol. 5, 3610-3616 (1985).
35. M. E. Furth, L. J. Davis, B. Fleurdelys and E. M. Scolnick, Monoclonal antibodies to the p21 products of the transforming gene of Harvey murine sarcoma virus and of the cellular ras gene family. J. Virol. 43, 294-304 (1982).
36. L. L. Vindeløv, I. J. Christensen and N. I. Nissen, A detergenttrypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3, 323-327 (1983).
37. H. F. van den Ingh, G. Griffioen and C. J. Cornelisse, Flow cytometric detection of aneuploidy in colorectal adenomas. Cancer Res. 45, 3392-3397 (1985).
38. G. W. Barendsen, Dose fractionation, dose rate, and isoeffect relationships for normal tissue responses. Int. J. Radiat. Oncol. Biol. Phys. 8, 1981-1997 (1982).
39. U. N. Kasid, R. R. Weichselbaum, T. Brennan, G. E. Mark and A. Dritschilo, Sensitivities of NIH/3T3-derived clonal cell lines to ionizing radiation: significance for gene transfer studies. Cancer Res. 49, 3396-3400 (1989).
40. K. F. Pirollo, R. Garner, S. Y. Yuan, L. Li, W. A. Blattner and E. H. Chang, Raf involvement in the simultaneous genetic transfer of the radioresistant and transforming phenotypes. Int. J. Radiat. Biol. 55, 783-796 (1989).
41. C. C. Ling and B. Endlich, Radioresistance induced by oncogenic transformation. Radiat. Res. 120, 267-279 (1989).
42. L. N. Su and J. B. Little, Prolonged cell cycle delay in radioresistant human cell lines transfected with activated ras oncogene and/or simian virus 40 T-antigen. Radiat. Res. 133, 73-79 (1993).
43. M. J. Arends, A. H. McGregor, N. J. Toft, E. J. H. Brown and A. H. Wyllie, Susceptibility to apoptosis is differentially regulated by c-myc and mutated ha-ras oncogenes and is associated with endonuclease availability. Br. J. Concer 68, 1127-1133 (1993).